Fundamental Analysis of Kilitch Drugs (India) Ltd

About the Company - Kilitch Drugs (India) Ltd

Kilitch Drugs(I) Ltd. is a Public Limited Listed company incorporated on 12/05/1992 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24239MH1992PLC066718 and registration number is 066718. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 105.16 Cr. and Equity Capital is Rs. 15.58 Cr. for the Year ended 31/03/2022.

INDUSTRY	ADDRESS	CONTACT
Pharmaceuticals	C-301/2, M.I.D.C., TTC Industrial Area, New Mumbai Maharashtra 400705	info@kilitch.com http://www.kilitch.com

Management
Name	Position Held
Mr. Mukund P Mehta	Managing Director
Mr. Bhavin Mukund Mehta	Whole Time Director
Mrs. Mira B Mehta	Whole Time Director
Mr. Hemang J Engineer	Independent Director
Mr. Venkita Subramanian Rajan	Independent Director
Prof. Vasudev Krishna Murti	Independent Director

Basic Stock Data of Kilitch Drugs (India) Ltd

Last Updated: July 26, 2024, 10:26 pm

Market Cap	578 Cr.
Current Price	358
High / Low	470/175
Stock P/E	42.6
Book Value	110
Dividend Yield	0.00 %
ROCE	13.5 %
ROE	8.41 %
Face Value	10.0
PEG Ratio	0.56

Data Source: screener.in

Kilitch Drugs (India) Ltd Quarterly Results

Month	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023
Sales	20.33	19.93	19.62	23.57	34.43	36.61	33.45	30.70	29.97	45.48	36.56	41.20	31.79
Expenses	17.31	19.61	18.71	19.92	33.66	31.57	30.03	26.75	25.99	39.26	30.38	32.58	29.51
Operating Profit	3.02	0.32	0.91	3.65	0.77	5.04	3.42	3.95	3.98	6.22	6.18	8.62	2.28
OPM %	14.85%	1.61%	4.64%	15.49%	2.24%	13.77%	10.22%	12.87%	13.28%	13.68%	16.90%	20.92%	7.17%
Other Income	0.37	1.51	1.05	0.17	1.31	0.38	0.97	0.24	0.69	1.02	0.56	0.49	2.96
Interest	0.12	0.16	0.13	0.12	0.24	0.71	0.67	1.75	1.29	1.21	1.50	1.51	1.60
Depreciation	0.50	0.50	0.44	0.70	0.20	1.13	0.82	0.89	0.93	0.91	0.71	0.82	0.81
Profit before tax	2.77	1.17	1.39	3.00	1.64	3.58	2.90	1.55	2.45	5.12	4.53	6.78	2.83
Tax %	21.30%	40.17%	47.48%	14.00%	62.80%	36.03%	40.00%	-25.16%	30.61%	43.16%	32.67%	24.93%	38.16%
Net Profit	2.18	0.71	0.72	2.58	0.61	2.30	1.74	1.94	1.71	2.90	3.06	5.09	1.74
EPS in Rs	1.43	0.46	0.76	1.39	0.72	1.86	1.34	1.56	1.52	2.28	2.16	2.95	1.81

Last Updated: July 11, 2024, 9:27 am

Kilitch Drugs (India) Ltd Quarterly Chart

Kilitch Drugs (India) Ltd Profit & Loss

Last Updated: July 10, 2024, 7:02 pm

Month	Mar 2010	Mar 2011	Mar 2012	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	TTM
Sales	143	146	108	19	21	27	51	82	53	68	114	140	155
Expenses	119	124	95	21	25	28	45	75	53	63	104	122	132
Operating Profit	23	22	13	-2	-4	-1	6	7	0	5	10	18	23
OPM %	16%	15%	12%	-9%	-19%	-2%	11%	9%	1%	8%	9%	13%	15%
Other Income	0	0	92	3	2	1	3	4	4	3	3	3	5
Interest	5	4	3	0	0	0	0	1	1	1	1	5	6
Depreciation	6	6	5	2	10	10	2	2	2	2	2	4	3
Profit before tax	13	13	97	-1	-12	-9	6	9	2	5	10	12	19
Tax %	22%	20%	22%	70%	4%	5%	16%	55%	48%	27%	35%	31%
Net Profit	10	10	76	-0	-11	-9	5	4	1	4	6	8	13
EPS in Rs	7.75	7.93	57.67	-0.22	-8.46	-6.72	3.75	2.49	0.54	2.43	4.73	6.71	9.20
Dividend Payout %	13%	13%	52%	0%	0%	0%	13%	20%	0%	0%	0%	0%

Kilitch Drugs (India) Ltd Profit & Loss Yearly Chart

Kilitch Drugs (India) Ltd Growth

Compounded Sales Growth
10 Years:	%
5 Years:	13%
3 Years:	31%
TTM:	11%

Compounded Profit Growth
10 Years:	%
5 Years:	37%
3 Years:	66%
TTM:	78%

Stock Price CAGR
10 Years:	32%
5 Years:	26%
3 Years:	20%
1 Year:	100%

Return on Equity
10 Years:	%
5 Years:	4%
3 Years:	6%
Last Year:	8%

Last Updated: July 25, 2024, 9:32 am

Kilitch Drugs (India) Ltd Balance Sheet

Last Updated: July 10, 2024, 7:02 pm

Month	Mar 2010	Mar 2011	Mar 2012	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Sep 2023
Equity Capital	13	13	13	13	13	13	14	15	15	15	16	16	16
Reserves	62	71	101	107	95	88	98	106	103	112	121	131	151
Borrowings	43	16	9	0	0	1	1	9	13	15	20	22	29
Other Liabilities	21	53	54	7	8	11	15	13	12	61	53	51	41
Total Liabilities	139	153	177	127	117	113	128	144	143	203	210	220	237
Fixed Assets	44	42	9	9	42	33	33	32	32	30	65	64	64
CWIP	22	43	0	0	0	1	3	20	30	65	3	4	3
Investments	1	0	138	72	49	53	56	53	52	60	71	62	66
Other Assets	72	68	30	46	25	26	35	38	30	47	71	90	104
Total Assets	139	153	177	127	117	113	128	144	143	203	210	220	237

Kilitch Drugs (India) Ltd Reserves and Borrowings Chart

Kilitch Drugs (India) Ltd Cash Flow

Month	Mar 2011	Mar 2012	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Cash from Operating Activity	22	-29	-8	17	1	1	0	4	46	6	3	-0
Cash from Investing Activity	-24	41	-31	-20	-2	-4	-14	-10	-38	-15	8	-10
Cash from Financing Activity	7	-9	-0	0	-0	6	17	1	2	7	-1	9
Net Cash Flow	6	2	-39	-2	-0	2	3	-5	10	-2	10	-1

Kilitch Drugs (India) Ltd Financial Efficiency Indicators

Month	Mar 2010	Mar 2011	Mar 2012	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Debtor Days	123	97	51	243	286	196	148	86	109	122	132	142
Inventory Days	46	62	12	124	110	84	39	36	70	35	28	10
Days Payable	44	37	19	124	154	184	108	33	89	525	239	200
Cash Conversion Cycle	125	121	44	243	241	96	79	89	89	-367	-79	-48
Working Capital Days	107	19	-114	197	237	124	100	79	108	-144	25	54
ROCE %		15%	8%		-10%	-9%	5%	6%	1%	3%	6%	10%

Kilitch Drugs (India) Ltd Financial Efficiency Indicators Chart

Kilitch Drugs (India) Ltd Share Holding Pattern

Month	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
Promoters	68.33%	68.25%	68.25%	68.25%	68.24%	68.24%	68.24%	68.24%	69.23%	69.23%	69.23%	69.23%
FIIs	0.00%	0.03%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Public	31.67%	31.73%	31.75%	31.75%	31.75%	31.75%	31.75%	31.76%	30.78%	30.76%	30.77%	30.77%
No. of Shareholders	8,740	9,129	9,133	9,209	9,380	9,435	9,522	9,573	9,002	9,062	9,525	9,620

Kilitch Drugs (India) Ltd Shareholding Pattern Chart

No. of Kilitch Drugs (India) Ltd Shareholders

This stock is not held by any mutual fund

Kilitch Drugs (India) Ltd ROCE Trend

Kilitch Drugs (India) Ltd EPS Trend

Kilitch Drugs (India) Ltd Key Financial Ratios

Month	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
FaceValue	10.00	10.00	10.00	10.00	10.00
Basic EPS (Rs.)	9.17	6.71	4.73	2.37	0.55
Diluted EPS (Rs.)	9.17	6.71	4.73	2.37	0.55
Cash EPS (Rs.)	10.52	7.59	5.57	3.71	1.84
Book Value[Excl.RevalReserv]/Share (Rs.)	109.23	96.64	90.03	83.56	78.05
Book Value[Incl.RevalReserv]/Share (Rs.)	109.23	96.64	90.03	83.56	78.05
Revenue From Operations / Share (Rs.)	95.99	89.59	73.31	44.22	34.55
PBDIT / Share (Rs.)	17.80	13.15	8.52	5.07	2.80
PBIT / Share (Rs.)	15.72	10.87	6.94	3.79	1.50
PBT / Share (Rs.)	12.03	7.71	6.17	3.30	1.04
Net Profit / Share (Rs.)	8.44	5.32	3.99	2.43	0.54
NP After MI And SOA / Share (Rs.)	9.08	6.71	4.73	2.37	0.54
PBDIT Margin (%)	18.54	14.67	11.62	11.47	8.10
PBIT Margin (%)	16.37	12.12	9.46	8.57	4.35
PBT Margin (%)	12.53	8.60	8.41	7.47	3.01
Net Profit Margin (%)	8.79	5.93	5.43	5.49	1.57
NP After MI And SOA Margin (%)	9.45	7.48	6.44	5.35	1.57
Return on Networth / Equity (%)	8.28	6.89	5.29	2.88	0.71
Return on Capital Employeed (%)	14.37	11.24	7.69	4.52	1.92
Return On Assets (%)	6.08	4.75	3.51	1.80	0.58
Total Debt / Equity (X)	0.17	0.14	0.14	0.11	0.10
Asset Turnover Ratio (%)	0.67	0.65	0.48	0.41	0.38
Current Ratio (X)	2.27	1.84	1.65	1.10	2.54
Quick Ratio (X)	2.21	1.81	1.57	1.05	2.29
Inventory Turnover Ratio (X)	26.22	21.16	14.04	8.31	7.10
Dividend Payout Ratio (NP) (%)	0.00	0.00	0.00	0.00	110.48
Dividend Payout Ratio (CP) (%)	0.00	0.00	0.00	0.00	32.74
Earning Retention Ratio (%)	0.00	0.00	0.00	0.00	-10.48
Cash Earning Retention Ratio (%)	0.00	0.00	0.00	0.00	67.26
Interest Coverage Ratio (X)	4.83	4.16	11.08	10.42	6.04
Interest Coverage Ratio (Post Tax) (X)	3.29	2.68	6.18	5.99	2.18
Enterprise Value (Cr.)	638.35	218.65	272.89	130.24	137.43
EV / Net Operating Revenue (X)	4.14	1.57	2.39	1.90	2.58
EV / EBITDA (X)	22.29	10.67	20.55	16.57	31.80
MarketCap / Net Operating Revenue (X)	4.06	1.56	2.29	1.83	2.35
Retention Ratios (%)	0.00	0.00	0.00	0.00	-10.48
Price / BV (X)	3.56	1.43	1.88	0.98	1.06
Price / Net Operating Revenue (X)	4.06	1.56	2.29	1.83	2.35
EarningsYield	0.02	0.04	0.02	0.02	0.01

Kilitch Drugs (India) Ltd Profitability Ratios (%)

Kilitch Drugs (India) Ltd Liquidity Ratios

Kilitch Drugs (India) Ltd Liquidity Ratios (%)

Kilitch Drugs (India) Ltd Interest Coverage Ratios (%)

Kilitch Drugs (India) Ltd Valuation Ratios

Fair Value

Fair Value: 401.97

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

Undervalued: 12.28% compared to the current price 358

Intrinsic Value: 708.72

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators along with EPS growth.

Undervalued: 97.97% compared to the current price 358

Last 5 Year EPS CAGR: 76.31%

*Investments are subject to market risks

Strength and Weakness of Kilitch Drugs (India) Ltd Stock

Strength	Weakness
The company has higher reserves (107.75 cr) compared to borrowings (11.50 cr), indicating strong financial stability. The company has shown consistent growth in sales (86.69 cr) and profit (12.62 cr) over the years.	The stock has a low average ROCE of 2.92%, which may not be favorable. The stock has a high average Working Capital Days of 66.00, which may not be favorable. The stock has a high average Cash Conversion Cycle of 52.75, which may not be favorable.

FAQ

What is the latest fair value of Kilitch Drugs (India) Ltd?

The latest fair value of Kilitch Drugs (India) Ltd is ₹401.97.

What is the Market Cap of Kilitch Drugs (India) Ltd?

The Market Cap of Kilitch Drugs (India) Ltd is 578 Cr..

What is the current Stock Price of Kilitch Drugs (India) Ltd as on 27 July 2024?

The current stock price of Kilitch Drugs (India) Ltd as on 27 July 2024 is 358.

What is the High / Low of Kilitch Drugs (India) Ltd stocks in FY 2024?

In FY 2024, the High / Low of Kilitch Drugs (India) Ltd stocks is 470/175.

What is the Stock P/E of Kilitch Drugs (India) Ltd?

The Stock P/E of Kilitch Drugs (India) Ltd is 42.6.

What is the Book Value of Kilitch Drugs (India) Ltd?

The Book Value of Kilitch Drugs (India) Ltd is 110.

What is the Dividend Yield of Kilitch Drugs (India) Ltd?

The Dividend Yield of Kilitch Drugs (India) Ltd is 0.00 %.

What is the ROCE of Kilitch Drugs (India) Ltd?

The ROCE of Kilitch Drugs (India) Ltd is 13.5 %.

What is the ROE of Kilitch Drugs (India) Ltd?

The ROE of Kilitch Drugs (India) Ltd is 8.41 %.

What is the Face Value of Kilitch Drugs (India) Ltd?

The Face Value of Kilitch Drugs (India) Ltd is 10.0.